The Great Grantsby G

Novo Nordisk Foundation

Challenge Programme 2027: Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections

DKK 30–75 million per grant (ca. EUR 4–10 million); total pool ca. EUR 20 million6 years

2-stage process: Stage 1 expression of interest, then shortlisted applicants invited to Stage 2 full proposal. Specific dates not stated in this segment.

Last verified:

This is the current call of theNovo Nordisk Foundation Challenge Programmeprogramme. The programme guide coverseligibility, budget, success rate and FAQacross every round.

Details

Funder Novo Nordisk Foundation
Budget DKK 30–75 million per grant (ca. EUR 4–10 million); total pool ca. EUR 20 million
Duration 6 years
Consortium Required — 2–4 research groups (main applicant + 1–3 co-applicants); at least one applicant must be based at a Danish institution; main applicant must be at a European (EU, Schengen Area, or UK) university, hospital, or non-profit
Application 2-stage: Stage 1 expression of interest → Stage 2 full proposal + online presentation to review panel
Eligible countries DK

Eligibility & scope

Early-stage proof-of-concept research on rapid, minimally invasive, affordable LRTI diagnostics and AMR susceptibility testing for point-of-care use in global settings. Research must be anchored at a research institution or non-profit; for-profit product development is ineligible. Main applicant must be tenured/tenure-track at a European (EU/Schengen/UK) institution with ≥75% commitment; at least one applicant must be ≥75% employed at a Danish institution. Industry partners may collaborate but cannot receive funding.

Related on Grantsby

View full call →
Share ✉ Email X LinkedIn WhatsApp

More from Novo Nordisk Foundation

Browse all open grants →

Does this grant match your research?

Sign up free to get a personalised match score and weekly alerts for grants like this.

Get started free